Kidney transplant
Conditions
Interventions
intervention group:All subjects received domestic mycophenolate sodium enteric coated tablets (EC-MPS, ruiyirong)+standard immunosuppressive therapy.
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.18-65 years old, regardless of gender; 2.He was diagnosed with end-stage renal disease and received living donor kidney transplantation; 3.It is planned to use domestic mycophenolate sodium enteric coated tablets (EC-MPS, ruiyirong) as one of the immunosuppressive regimens after operation; 4.The preoperative evaluation was consistent with the indications of transplantation, and there were no serious complications; 5.They signed the informed consent and were willing to participate in the study and complete the follow-up.
Exclusion criteria
Exclusion criteria: 1.Allergic history to domestic mycophenolate sodium enteric coated tablets (EC-MPS, ruiyirong) or other related drugs; 2.Previous severe cardiovascular, liver or other systemic diseases affected the prognosis; 3.Other experimental treatments were needed after operation; 4.Pregnant or lactating women; 5.The compliance was poor and the follow-up could not be completed. 6.Other reasons that the researcher determines are not suitable for participating in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of acute rejection within 6 months post-surgery;Renal function parameters; | — |
Countries
China
Contacts
Public ContactDingxiaoming
The First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed